Fig. 4From: Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapyThe anti-tumor immune responses induced by co-delivered NPs with STING agonists and anti-tumor agents. Note: CpG ODNs + cGAMP + TRP-2 particles are nanoporous (40–100 nm) microparticles for STING agonismBack to article page